首页> 外文期刊>Experimental Neurology >Inhibition of Rac1 ameliorates neuronal oxidative stress damage via reducing Bcl-2/Rac1 complex formation in mitochondria through PI3K/Akt/mTOR pathway
【24h】

Inhibition of Rac1 ameliorates neuronal oxidative stress damage via reducing Bcl-2/Rac1 complex formation in mitochondria through PI3K/Akt/mTOR pathway

机译:RAC1的抑制通过PI3K / AKT / MTOR途径降低线粒体中的Bcl-2 / Rac1复合物,通过降低Bcl-2 / Rac1复合物形成来改善神经元氧化应激损伤

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Although the neuroprotective effects of Rac1 inhibition have been reported in various cerebral ischemic models, the molecular mechanisms of action have not yet been fully elucidated. In this study, we investigated whether the inhibition of Rac1 provided neuroprotection in a diabetic rat model of focal cerebral ischemia and hyperglycemia-exposed PC-12 cells. Intracerebroventricular administration of lentivirus expressing the Rac1 small hairpin RNA (shRNA) and specific Rac1 inhibitor NSC23766 not only decreased the infarct volumes and improved neurologic deficits with a correlated significant activation of mitochondrial DNA specific proteins, such as OGG1 and POLG, but also elevated Bcl-2 S70 phosphorylation in mitochondria. Furthermore, the levels of p-PI3K, p-Akt and p-mTOR increased, while 8-OHdG, ROS production and Bcl-2/Rac1 complex formation in mitochondria reduced in both Rac1-shRNA- and NSC23766-treated rats. Moreover, to confirm our in vivo observations, inhibition of Rac1 activity by NSC23766 suppressed the interactions between Bcl-2 and Rac1 in the mitochondria of PC-12 cells cultured in high glucose conditions and protected PC-12 cells from high glucose-induced neurotoxicity. More importantly, these beneficial effects of Rac1 inhibition were abolished by PI3K inhibitor LY294002. In contrast to NSC23766 treatment, LY294002 had little effect on the decrement of p-PTEN level. Taken together, these findings revealed novel neuroprotective roles of Rac1 inhibition against cerebral ischemic reperfusion injury in vivo and high glucose-induced neurotoxicity in PC-12 cells in vitro , by reducing Bcl-2/Rac1 complex formation in mitochondria through the activation of PI3K/Akt/mTOR survival pathway. Highlights ? Inhibiting Rac1 conferred significant neuroprotection in vivo and in vitro model. ? Rac1 inhibition efficaciously alleviated mitochondrial oxidative stress, by activating PI3K/Akt/mTOR pathway
机译:摘要虽然在各种脑缺血模型中报道了RAC1抑制的神经保护作用,但尚未完全阐明的作用的分子机制。在这项研究中,我们研究了RAC1的抑制是否在局灶性脑缺血和高血糖暴露的PC-12细胞中提供了神经保护作用。表达RAC1小发夹RNA(SHRNA)和特定RAC1抑制剂NSC23766的脑内脑室施用不仅降低了梗塞体积和改善的神经系统缺陷,具有相关的显着激活线粒体DNA特异性蛋白质,例如OGG1和POLG,但也升高了BCL- 2 S70线粒体磷酸化。此外,P-PI3K,P-AKT和P-MTOR的水平增加,而8-OHDG,ROS生产和BCL-2 / RAC1在线粒体中的复杂形成在Rac1-ShRNA和NSC23766处理的大鼠中减少。此外,为了确认我们的体内观察,NSC23766的RAC1活性抑制了在高葡萄糖条件培养的PC-12细胞的线粒体中BCL-2和RAC1之间的相互作用,并受到高葡萄糖诱导的神经毒性的保护的PC-12细胞。更重要的是,通过PI3K抑制剂Ly294002废除了Rac1抑制的这些有益效果。与NSC23766治疗相比,LY294002对P-PTEN水平的减少几乎没有影响。在一起,这些发现揭示了Rac1抑制脑缺血再灌注损伤的新型神经保护作用,并通过PI3K的激活减少了线粒体中的Bcl-2 / Rac1复合物,通过激活了PI-12细胞中的PC-12细胞中的高葡萄糖诱导的神经毒性。/ AKT / MTOR存活途径。强调 ?抑制RAC1在体内和体外模型中赋予显着的神经保护作用。还RAC1抑制效果效果缓解线粒体氧化应激,通过激活PI3K / AKT / MTOR途径

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号